Skip to main content

Prevalence of ANCAs in Patients on Maintenance Haemodialysis

  • Chapter
ANCA-Associated Vasculitides

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 336))

Summary

ANCA analysis as evaluated by concomitant determination of ANCA-IF, PR3AB and MPO-AB in a larger cohort of dialysis patients disclosed that the prevalence of Wegener’s granulomatosis and microscopic polyarteritis in Germany is 4 fold higher than hitherto believed. Low ANCA-IF titers without measurable PR3-AB or MPO-AB are not pathological-they resemble an increased autoimmune tendency of the dialysis patients.

According to the european dialysis and transplantation association (EDTA)registry the incidence of Wegener’s granulomatosis (WG) and microscopic polyarteritis (MP) on haemodialysis (HD) in Germany is 0.5% and the prevalence is in the same range (1), In contrast to Germany the incidence in France and Great Britain is above 2%. This is mainly based on histologically proven diseases, which can identify only 1/3 of all affected cases, corresponding to our own experience. With the advent of ANCA serology, WG and MP can be diagnosed more easily. C-ANCA with proteinase 3-antibodies (PR3-AB) is typical of WG, and p-ANCA with myeloperoxidaseantibodies (MPO-AB) is typical of MP in our country. Since a considerable number of patients are on chronic HD without knowledge of their underlying renal disease we studied the prevalence of ANCAs in a larger cohort of HD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Combined report on regular dialysis and transplantation in Europe XIX 1988, 1989, Nephrol.Dial.Transpl.4, Supp1. 4

    Google Scholar 

  2. Rasmussen,N., Sjölin, C., Isaksson, B., Bygren, P., Wieslander, J. 1990, An Elisa for the detection of antineutrophil cytoplasm antibodies, J.Immunol.Meth. 127: 139–145

    Article  Google Scholar 

  3. Nolph, K.D.,Ghods, A.J., Sharp, G.C., Siemsen, A.W.,1978, Antibodies to nuclear antigens in patients with renal failure, J.Lab.Clin.Med. 91: 559–567

    Google Scholar 

  4. Mayet, W.J., Wandel, E., Herman, E., Meyer zum Büschenfelde, K.H.,1988, Autoantikörper bei chronischen Dialysepatienten, Nieren, and Hochdruckkrankheiten 17: 381

    Google Scholar 

  5. Andrassy, K., Koderisch, J., Schäfer, A., Waldherr, R., 1990, Idiopathic rapidly progressive crescentic glomerulonephritis with myeloperoxidase antibodies - a new entitiy linked to female sex? Nephron 56: 99–100

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Weidemann, S., Apenberg, S., Andrassy, K. (1993). Prevalence of ANCAs in Patients on Maintenance Haemodialysis. In: Gross, W.L. (eds) ANCA-Associated Vasculitides. Advances in Experimental Medicine and Biology, vol 336. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9182-2_74

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9182-2_74

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9184-6

  • Online ISBN: 978-1-4757-9182-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics